Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2112732-01-9 | N-(Propargyl-peg4-carbonyl)-n-bis(peg1-methyl ester) | AA019E9V | MFCD30723219
1198080-03-3 | Propargyl-PEG6-azide | AA019EEF | MFCD31561110
29652-81-1 | 1-(3,4,5-trimethoxyphenyl)propan-1-ol | AA019EHU | MFCD15478766
914942-86-2 | 2,6-Dichloro-n4-methylpyridine-3,4-diamine | AA019EL5 | MFCD20685342
1217790-09-4 | (1R,2R,3R,4S)-3-[(2-methylpropan-2-yl)oxycarbonylamino]bicyclo[2.2.1]heptane-2-carboxylic acid | AA019ENY | MFCD31579939
951259-22-6 | 1-Piperidinecarboxylic acid, 4-(5-bromo-2-thienyl)-, 1,1-dimethylethyl ester | AA019ER8 | MFCD28054531
1699007-40-3 | 6-Chloro-5-methyl-3,6-dihydropyridazin-3-amine | AA019EUR | MFCD22379977
514844-65-6 | 4-bromo-1-methoxy-2-Naphthalenecarboxaldehyde | AA019EXT | MFCD31652794
53714-56-0 | Leuprorelin | AA019FPD | MFCD00167544
1258638-62-8 | 2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)-2,2-difluoroacetic acid | AA019G1N | MFCD18433769